Centre for Bioengineering and Biotechnology
University of Waterloo, East Campus 4, Room 2001
200 University Avenue West
Waterloo , Ontario, N2L 3G1 Canada
519-888-4567 Ext 32732
The Centre for Bioengineering and Biotechnology (CBB) is focused on advancing research and innovation by building healthy, active interdisciplinary partnerships between researchers, industry leaders and health professionals. The global COVID-19 crisis makes these connections more important than ever.
CBB is working hard to support research, healthcare, industry and to mobilize the expertise at Waterloo to respond to the challenges related to COVID-19. Industry partners, committees and working groups both at the University of Waterloo and externally are seeking expertise, resources and facilities that will support solutions for the current and future global pandemics.
CanCOVID is Canada's federally-mandated, expert-led COVID-19 research response.
The CanCOVID Platform is by invitation, and is restricted to verified members of the COVID-19 expert research and response community. This includes, for example, researchers with recognized expertise in:
A collaboration platform identifying industry and research experts across Ontario to respond to the COVID-19 crisis. This collaboration platform is for individuals or companies whose products are not yet commercialized or procurement-ready.
The University of Waterloo acknowledges that much of our work takes place on the traditional territory of the Neutral, Anishinaabeg and Haudenosaunee peoples. Our main campus is situated on the Haldimand Tract, the land granted to the Six Nations that includes six miles on each side of the Grand River. Our active work toward reconciliation takes place across our campuses through research, learning, teaching, and community building, and is co-ordinated within the Office of Indigenous Relations.